B
Bull
Bull · 25%VERO
$2.19
Szenariopreis
$1.140
-0.039 (-3.39%)Zum Schluss
Loading chart…
- High
- 1.280
- Open
- 1.160
- VWAP
- 1.16
- Vol
- 560.44K
- Mkt Cap
- 5.11M
- Low
- 1.065
- Amount
- 651.04K
- EV/EBITDA, TTM
- 0.00
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Bewertungskennzahlen
The current forward P/E ratio for Venus Concept Inc (VERO) is -0.13, compared to its 5-year average forward P/E of -1.08.
Alphio AI Price Scenarios for VERO
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Event-Zeitleiste
News
7.507-28GlobenewswireVenus Concept Enters Exclusive Distribution Agreement with HIRONIC
7.507-28NewsfilterVenus Concept Enters Exclusive Distribution Agreement with HIRONIC for Doublo 2.0
- 5.005-13Newsfilter
Venus Concept Announces Senior Leadership Changes
8.505-04moomooVENUS AEROSPACE CORP ANNOUNCES $63 MILLION RAISED IN EQUITY FINANCING OUT OF APPROXIMATELY $100 MILLION TOTAL OFFERING, ACCORDING TO SEC FILING
- 8.504-01Newsfilter
Venus Concept Completes Short-Form Merger Transaction
VERO FAQ — answered by Alphio AI
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.